000289801 001__ 289801
000289801 005__ 20240428010954.0
000289801 0247_ $$2doi$$a10.1073/pnas.2313971121
000289801 0247_ $$2pmid$$apmid:38662573
000289801 0247_ $$2ISSN$$a0027-8424
000289801 0247_ $$2ISSN$$a1091-6490
000289801 0247_ $$2altmetric$$aaltmetric:162854765
000289801 037__ $$aDKFZ-2024-00880
000289801 041__ $$aEnglish
000289801 082__ $$a500
000289801 1001_ $$00000-0002-9488-5545$$aBosch, Thomas C G$$b0
000289801 245__ $$aThe potential importance of the built-environment microbiome and its impact on human health.
000289801 260__ $$aWashington, DC$$bNational Acad. of Sciences$$c2024
000289801 3367_ $$2DRIVER$$aarticle
000289801 3367_ $$2DataCite$$aOutput Types/Journal article
000289801 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1714138231_27237
000289801 3367_ $$2BibTeX$$aARTICLE
000289801 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000289801 3367_ $$00$$2EndNote$$aJournal Article
000289801 520__ $$aThere is increasing evidence that interactions between microbes and their hosts not only play a role in determining health and disease but also in emotions, thought, and behavior. Built environments greatly influence microbiome exposures because of their built-in highly specific microbiomes coproduced with myriad metaorganisms including humans, pets, plants, rodents, and insects. Seemingly static built structures host complex ecologies of microorganisms that are only starting to be mapped. These microbial ecologies of built environments are directly and interdependently affected by social, spatial, and technological norms. Advances in technology have made these organisms visible and forced the scientific community and architects to rethink gene-environment and microbe interactions respectively. Thus, built environment design must consider the microbiome, and research involving host-microbiome interaction must consider the built-environment. This paradigm shift becomes increasingly important as evidence grows that contemporary built environments are steadily reducing the microbial diversity essential for human health, well-being, and resilience while accelerating the symptoms of human chronic diseases including environmental allergies, and other more life-altering diseases. New models of design are required to balance maximizing exposure to microbial diversity while minimizing exposure to human-associated diseases. Sustained trans-disciplinary research across time (evolutionary, historical, and generational) and space (cultural and geographical) is needed to develop experimental design protocols that address multigenerational multispecies health and health equity in built environments.
000289801 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000289801 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000289801 650_7 $$2Other$$aAnthropocene
000289801 650_7 $$2Other$$aarchitectural design
000289801 650_7 $$2Other$$aevolution
000289801 650_7 $$2Other$$ametaorganism
000289801 650_7 $$2Other$$amicrobiome
000289801 650_2 $$2MeSH$$aHumans
000289801 650_2 $$2MeSH$$aBuilt Environment
000289801 650_2 $$2MeSH$$aMicrobiota: physiology
000289801 650_2 $$2MeSH$$aAnimals
000289801 7001_ $$00009-0003-8942-479X$$aWigley, Mark$$b1
000289801 7001_ $$00009-0009-6526-9338$$aColomina, Beatriz$$b2
000289801 7001_ $$aBohannan, Brendan$$b3
000289801 7001_ $$00000-0002-9037-7578$$aMeggers, Forrest$$b4
000289801 7001_ $$00000-0003-2722-9414$$aAmato, Katherine R$$b5
000289801 7001_ $$00000-0002-5942-4444$$aAzad, Meghan B$$b6
000289801 7001_ $$00000-0003-2447-2443$$aBlaser, Martin J$$b7
000289801 7001_ $$aBrown, Kate$$b8
000289801 7001_ $$00000-0002-8879-6159$$aDominguez-Bello, Maria Gloria$$b9
000289801 7001_ $$aEhrlich, Stanislav Dusko$$b10
000289801 7001_ $$0P:(DE-He78)725ad944da4e1ea60389fe9dbbed2c7c$$aElinav, Eran$$b11$$udkfz
000289801 7001_ $$00000-0001-5303-6128$$aFinlay, B Brett$$b12
000289801 7001_ $$00000-0003-3629-1949$$aGeddie, Kate$$b13
000289801 7001_ $$00000-0002-7303-854X$$aGeva-Zatorsky, Naama$$b14
000289801 7001_ $$00000-0003-2873-8544$$aGiles-Vernick, Tamara$$b15
000289801 7001_ $$00000-0002-0114-1978$$aGros, Philippe$$b16
000289801 7001_ $$00000-0001-6004-9955$$aGuillemin, Karen$$b17
000289801 7001_ $$00000-0002-3713-7866$$aHaraoui, Louis-Patrick$$b18
000289801 7001_ $$00000-0002-8290-1122$$aJohnson, Elizabeth$$b19
000289801 7001_ $$00000-0002-7711-7288$$aKeck, Frédéric$$b20
000289801 7001_ $$00000-0003-4369-0884$$aLorimer, Jamie$$b21
000289801 7001_ $$00000-0002-6046-6238$$aMcFall-Ngai, Margaret J$$b22
000289801 7001_ $$00000-0002-4112-3010$$aNichter, Mark$$b23
000289801 7001_ $$00000-0001-8903-3738$$aPettersson, Sven$$b24
000289801 7001_ $$00000-0002-0314-4160$$aPoinar, Hendrik$$b25
000289801 7001_ $$00000-0002-8273-7393$$aRees, Tobias$$b26
000289801 7001_ $$00000-0002-7542-1577$$aTropini, Carolina$$b27
000289801 7001_ $$00000-0002-4425-1253$$aUndurraga, Eduardo A$$b28
000289801 7001_ $$aZhao, Liping$$b29
000289801 7001_ $$00000-0003-1766-5466$$aMelby, Melissa K$$b30
000289801 773__ $$0PERI:(DE-600)1461794-8$$a10.1073/pnas.2313971121$$gVol. 121, no. 20, p. e2313971121$$n20$$pe2313971121$$tProceedings of the National Academy of Sciences of the United States of America$$v121$$x0027-8424$$y2024
000289801 909CO $$ooai:inrepo02.dkfz.de:289801$$pVDB
000289801 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)725ad944da4e1ea60389fe9dbbed2c7c$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000289801 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000289801 9141_ $$y2024
000289801 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium$$d2023-08-26$$wger
000289801 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bP NATL ACAD SCI USA : 2022$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)1060$$2StatID$$aDBCoverage$$bCurrent Contents - Agriculture, Biology and Environmental Sciences$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-26
000289801 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bP NATL ACAD SCI USA : 2022$$d2023-08-26
000289801 9201_ $$0I:(DE-He78)D480-20160331$$kD480$$lMikrobiom und Krebs$$x0
000289801 9201_ $$0I:(DE-He78)F220-20160331$$kF220$$lMikrobiom und Krebs$$x1
000289801 980__ $$ajournal
000289801 980__ $$aVDB
000289801 980__ $$aI:(DE-He78)D480-20160331
000289801 980__ $$aI:(DE-He78)F220-20160331
000289801 980__ $$aUNRESTRICTED